AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study Post author:Sam Post published:December 3, 2017 Post category:BioPharma Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries. Source: BioSpace You Might Also Like Eli Lilly Shakes Up Cancer R&D Strategy, Seeks New Home for Seven Pipeline Drugs July 24, 2017 Pfizer's $15B Consumer Health Biz May be on GlaxoSmithKline's Shopping List October 25, 2017 Colorado State University And Synaptive Medical Collaborate To Better Detect Brain Tumors May 23, 2017
Colorado State University And Synaptive Medical Collaborate To Better Detect Brain Tumors May 23, 2017
